"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity."
Experts warn it could takeup to 12 years for many patients to access Mounjaro due to NHS capacity issues.
Healthy obesity is defined as having a BMI of 25 kg/m² or higher without metabolic diseases or with only one metabolic disease.